Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Developmental aspects of immunologically characterized proteins.

F W Falkenberg, W Gantenberg, I Jürgenliemk

Clinical Biochemistry

|February 1, 1983

Summary

Hybridoma technology enables the creation of specific monoclonal antibodies, overcoming previous limitations in developing clinical tests for antigenic proteins. This advancement allows for precise detection and quantification of diagnostic markers in various samples.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to: Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers.

Internal and emergency medicine·2023

Same author

Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.

Scientific reports·2023

Same author

Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers.

Internal and emergency medicine·2021

Same author

A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2021

Same author

In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).

BMC infectious diseases·2021

Same author

Sink drains as reservoirs of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in a Belgian intensive care unit: relation to patients investigated by whole-genome sequencing.

The Journal of hospital infection·2021

Area of Science:

Immunology
Biotechnology
Clinical Diagnostics

Background:

Clinical testing for antigenic proteins has historically been limited due to technical challenges.
Developing reliable diagnostic tests for antigens, rather than enzymes, posed significant hurdles.

Purpose of the Study:

To introduce hybridoma technology as a solution for developing clinical tests for antigenic proteins.
To evaluate the advantages and disadvantages of monoclonal antibodies in clinical diagnostics.
To discuss future applications of monoclonal antibodies in diagnosis and therapy.

Main Methods:

Utilizing hybridoma technology to generate specific monoclonal antibodies against tissue antigens.
Developing diagnostic reagents and assays for detecting and quantifying tissue markers.

Related Experiment Videos

Evaluating monoclonal antibodies using human kidney tissue antigens as a model.

Main Results:

Hybridoma technology overcomes the need for high-purity antigens in antibody development.
Specific monoclonal antibodies can be generated against determinants in any tissue or extract.
Diagnostic marker molecules, previously inaccessible, can now be detected and quantified.

Conclusions:

Monoclonal antibodies produced via hybridoma technology represent a significant advancement in clinical diagnostics.
These antibodies facilitate the development of novel tests for antigenic proteins and tissue markers.
Future applications of this technology extend to both clinical diagnosis and therapeutic interventions.